Global Radiopharmaceuticals Market Growth 2020-2025

Publisher Name :
Date: 21-Sep-2020
No. of pages: 158

According to this study, over the next five years the Radiopharmaceuticals market will register a 8.3%% CAGR in terms of revenue, the global market size will reach $ 7754.3 million by 2025, from $ 5637 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Radiopharmaceuticals business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Radiopharmaceuticals market by product type, application, key manufacturers and key regions and countries.

This study specially analyses the impact of Covid-19 outbreak on the Radiopharmaceuticals, covering the supply chain analysis, impact assessment to the Radiopharmaceuticals market size growth rate in several scenarios, and the measures to be undertaken by Radiopharmaceuticals companies in response to the COVID-19 epidemic.

Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.

- Diagnostic Radioisotopes

- Therapeutic Radioisotopes

Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.

- Oncology

- Cardiology

- Other

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

- Americas

- United States

- Canada

- Mexico

- Brazil

- APAC

- China

- Japan

- Korea

- Southeast Asia

- India

- Australia

- Europe

- Germany

- France

- UK

- Italy

- Russia

- Middle East & Africa

- Egypt

- South Africa

- Israel

- Turkey

- GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.

- Bracco Imaging

- Jubilant Pharma

- Bayer

- Nordion

- Triad Isotopes

- Mallinckrodt

- GE Healthcare

- Lantheus

- China Isotope & Radiation

- IBA Group

- Eli Lilly

- Dongcheng

- SIEMENS

- Navidea

- Advanced Accelerator Applications

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

- To study and analyze the global Radiopharmaceuticals consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.

- To understand the structure of Radiopharmaceuticals market by identifying its various subsegments.

- Focuses on the key global Radiopharmaceuticals manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.

- To analyze the Radiopharmaceuticals with respect to individual growth trends, future prospects, and their contribution to the total market.

- To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

- To project the consumption of Radiopharmaceuticals submarkets, with respect to key regions (along with their respective key countries).

- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

- To strategically profile the key players and comprehensively analyze their growth strategies.

Global Radiopharmaceuticals Market Growth 2020-2025

Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Radiopharmaceuticals Consumption 2015-2025
2.1.2 Radiopharmaceuticals Consumption CAGR by Region
2.2 Radiopharmaceuticals Segment by Type
2.2.1 Diagnostic Radioisotopes
2.2.2 Therapeutic Radioisotopes
2.3 Radiopharmaceuticals Consumption by Type
2.3.1 Global Radiopharmaceuticals Consumption Market Share by Type (2015-2020)
2.3.2 Global Radiopharmaceuticals Revenue and Market Share by Type (2015-2020)
2.3.3 Global Radiopharmaceuticals Sale Price by Type (2015-2020)
2.4 Radiopharmaceuticals Segment by Application
2.4.1 Oncology
2.4.2 Cardiology
2.4.3 Other
2.5 Radiopharmaceuticals Consumption by Application
2.5.1 Global Radiopharmaceuticals Consumption Market Share by Type (2015-2020)
2.5.2 Global Radiopharmaceuticals Value and Market Share by Type (2015-2020)
2.5.3 Global Radiopharmaceuticals Sale Price by Type (2015-2020)

3 Global Radiopharmaceuticals by Company
3.1 Global Radiopharmaceuticals Sales Market Share by Company
3.1.1 Global Radiopharmaceuticals Sales by Company (2018-2020)
3.1.2 Global Radiopharmaceuticals Sales Market Share by Company (2018-2020)
3.2 Global Radiopharmaceuticals Revenue Market Share by Company
3.2.1 Global Radiopharmaceuticals Revenue by Company (2018-2020)
3.2.2 Global Radiopharmaceuticals Revenue Market Share by Company (2018-2020)
3.3 Global Radiopharmaceuticals Sale Price by Company
3.4 Global Radiopharmaceuticals Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Radiopharmaceuticals Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Radiopharmaceuticals Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Radiopharmaceuticals by Regions
4.1 Radiopharmaceuticals by Regions
4.2 Americas Radiopharmaceuticals Consumption Growth
4.3 APAC Radiopharmaceuticals Consumption Growth
4.4 Europe Radiopharmaceuticals Consumption Growth
4.5 Middle East & Africa Radiopharmaceuticals Consumption Growth

5 Americas
5.1 Americas Radiopharmaceuticals Consumption by Countries
5.1.1 Americas Radiopharmaceuticals Consumption by Countries (2015-2020)
5.1.2 Americas Radiopharmaceuticals Value by Countries (2015-2020)
5.2 Americas Radiopharmaceuticals Consumption by Type
5.3 Americas Radiopharmaceuticals Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC Radiopharmaceuticals Consumption by Regions
6.1.1 APAC Radiopharmaceuticals Consumption by Regions (2015-2020)
6.1.2 APAC Radiopharmaceuticals Value by Regions (2015-2020)
6.2 APAC Radiopharmaceuticals Consumption by Type
6.3 APAC Radiopharmaceuticals Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions

7 Europe
7.1 Europe Radiopharmaceuticals by Countries
7.1.1 Europe Radiopharmaceuticals Consumption by Countries (2015-2020)
7.1.2 Europe Radiopharmaceuticals Value by Countries (2015-2020)
7.2 Europe Radiopharmaceuticals Consumption by Type
7.3 Europe Radiopharmaceuticals Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
8.1 Middle East & Africa Radiopharmaceuticals by Countries
8.1.1 Middle East & Africa Radiopharmaceuticals Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Radiopharmaceuticals Value by Countries (2015-2020)
8.2 Middle East & Africa Radiopharmaceuticals Consumption by Type
8.3 Middle East & Africa Radiopharmaceuticals Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Radiopharmaceuticals Distributors
10.3 Radiopharmaceuticals Customer

11 Global Radiopharmaceuticals Market Forecast
11.1 Global Radiopharmaceuticals Consumption Forecast (2021-2025)
11.2 Global Radiopharmaceuticals Forecast by Regions
11.2.1 Global Radiopharmaceuticals Forecast by Regions (2021-2025)
11.2.2 Global Radiopharmaceuticals Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Radiopharmaceuticals Forecast by Type
11.8 Global Radiopharmaceuticals Forecast by Application

12 Key Players Analysis
12.1 Bracco Imaging
12.1.1 Company Information
12.1.2 Radiopharmaceuticals Product Offered
12.1.3 Bracco Imaging Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 Bracco Imaging Latest Developments
12.2 Jubilant Pharma
12.2.1 Company Information
12.2.2 Radiopharmaceuticals Product Offered
12.2.3 Jubilant Pharma Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 Jubilant Pharma Latest Developments
12.3 Bayer
12.3.1 Company Information
12.3.2 Radiopharmaceuticals Product Offered
12.3.3 Bayer Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 Bayer Latest Developments
12.4 Nordion
12.4.1 Company Information
12.4.2 Radiopharmaceuticals Product Offered
12.4.3 Nordion Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 Nordion Latest Developments
12.5 Triad Isotopes
12.5.1 Company Information
12.5.2 Radiopharmaceuticals Product Offered
12.5.3 Triad Isotopes Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 Triad Isotopes Latest Developments
12.6 Mallinckrodt
12.6.1 Company Information
12.6.2 Radiopharmaceuticals Product Offered
12.6.3 Mallinckrodt Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 Mallinckrodt Latest Developments
12.7 GE Healthcare
12.7.1 Company Information
12.7.2 Radiopharmaceuticals Product Offered
12.7.3 GE Healthcare Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 GE Healthcare Latest Developments
12.8 Lantheus
12.8.1 Company Information
12.8.2 Radiopharmaceuticals Product Offered
12.8.3 Lantheus Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 Lantheus Latest Developments
12.9 China Isotope & Radiation
12.9.1 Company Information
12.9.2 Radiopharmaceuticals Product Offered
12.9.3 China Isotope & Radiation Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2018-2020)
12.9.4 Main Business Overview
12.9.5 China Isotope & Radiation Latest Developments
12.10 IBA Group
12.10.1 Company Information
12.10.2 Radiopharmaceuticals Product Offered
12.10.3 IBA Group Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2018-2020)
12.10.4 Main Business Overview
12.10.5 IBA Group Latest Developments
12.11 Eli Lilly
12.11.1 Company Information
12.11.2 Radiopharmaceuticals Product Offered
12.11.3 Eli Lilly Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2018-2020)
12.11.4 Main Business Overview
12.11.5 Eli Lilly Latest Developments
12.12 Dongcheng
12.12.1 Company Information
12.12.2 Radiopharmaceuticals Product Offered
12.12.3 Dongcheng Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2018-2020)
12.12.4 Main Business Overview
12.12.5 Dongcheng Latest Developments
12.13 SIEMENS
12.13.1 Company Information
12.13.2 Radiopharmaceuticals Product Offered
12.13.3 SIEMENS Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2018-2020)
12.13.4 Main Business Overview
12.13.5 SIEMENS Latest Developments
12.14 Navidea
12.14.1 Company Information
12.14.2 Radiopharmaceuticals Product Offered
12.14.3 Navidea Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2018-2020)
12.14.4 Main Business Overview
12.14.5 Navidea Latest Developments
12.15 Advanced Accelerator Applications
12.15.1 Company Information
12.15.2 Radiopharmaceuticals Product Offered
12.15.3 Advanced Accelerator Applications Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2018-2020)
12.15.4 Main Business Overview
12.15.5 Advanced Accelerator Applications Latest Developments

13 Research Findings and Conclusion

List of Tables

Table 1. Research Methodology
Table 2. Data Source
Table 3. Radiopharmaceuticals Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of Diagnostic Radioisotopes
Table 5. Major Players of Therapeutic Radioisotopes
Table 6. Global Consumption Sales by Type (2015-2020)
Table 7. Global Radiopharmaceuticals Consumption Market Share by Type (2015-2020)
Table 8. Global Radiopharmaceuticals Revenue by Type (2015-2020) ($ million)
Table 9. Global Radiopharmaceuticals Value Market Share by Type (2015-2020) ($ Millions)
Table 10. Global Radiopharmaceuticals Sale Price by Type (2015-2020)
Table 11. Global Consumption Sales by Application (2015-2020)
Table 12. Global Radiopharmaceuticals Consumption Market Share by Application (2015-2020)
Table 13. Global Radiopharmaceuticals Value by Application (2015-2020)
Table 14. Global Radiopharmaceuticals Value Market Share by Application (2015-2020)
Table 15. Global Radiopharmaceuticals Sale Price by Application (2015-2020)
Table 16. Global Radiopharmaceuticals Sales by Company (2017-2019) (K Dose)
Table 17. Global Radiopharmaceuticals Sales Market Share by Company (2017-2019)
Table 18. Global Radiopharmaceuticals Revenue by Company (2017-2019) ($ Millions)
Table 19. Global Radiopharmaceuticals Revenue Market Share by Company (2017-2019)
Table 20. Global Radiopharmaceuticals Sale Price by Company (2017-2019)
Table 21. Global Radiopharmaceuticals Manufacturing Base Distribution and Sales Area by Manufacturers
Table 22. Players Radiopharmaceuticals Products Offered
Table 23. Radiopharmaceuticals Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 24. Global Radiopharmaceuticals Consumption by Regions 2015-2020 (K Dose)
Table 25. Global Radiopharmaceuticals Consumption Market Share by Regions 2015-2020
Table 26. Global Radiopharmaceuticals Value by Regions 2015-2020 ($ Millions)
Table 27. Global Radiopharmaceuticals Value Market Share by Regions 2015-2020
Table 28. Americas Radiopharmaceuticals Consumption by Countries (2015-2020) (K Dose)
Table 29. Americas Radiopharmaceuticals Consumption Market Share by Countries (2015-2020)
Table 30. Americas Radiopharmaceuticals Value by Countries (2015-2020) ($ Millions)
Table 31. Americas Radiopharmaceuticals Value Market Share by Countries (2015-2020)
Table 32. Americas Radiopharmaceuticals Consumption by Type (2015-2020) (K Dose)
Table 33. Americas Radiopharmaceuticals Consumption Market Share by Type (2015-2020)
Table 34. Americas Radiopharmaceuticals Consumption by Application (2015-2020) (K Dose)
Table 35. Americas Radiopharmaceuticals Consumption Market Share by Application (2015-2020)
Table 36. APAC Radiopharmaceuticals Consumption by Countries (2015-2020) (K Dose)
Table 37. APAC Radiopharmaceuticals Consumption Market Share by Countries (2015-2020)
Table 38. APAC Radiopharmaceuticals Value by Regions (2015-2020) ($ Millions)
Table 39. APAC Radiopharmaceuticals Value Market Share by Regions (2015-2020)
Table 40. APAC Radiopharmaceuticals Consumption by Type (2015-2020) (K Dose)
Table 41. APAC Radiopharmaceuticals Consumption Market Share by Type (2015-2020)
Table 42. APAC Radiopharmaceuticals Consumption by Application (2015-2020) (K Dose)
Table 43. APAC Radiopharmaceuticals Consumption Market Share by Application (2015-2020)
Table 44. Europe Radiopharmaceuticals Consumption by Countries (2015-2020) (K Dose)
Table 45. Europe Radiopharmaceuticals Consumption Market Share by Countries (2015-2020)
Table 46. Europe Radiopharmaceuticals Value by Countries (2015-2020) ($ Millions)
Table 47. Europe Radiopharmaceuticals Value Market Share by Countries (2015-2020)
Table 48. Europe Radiopharmaceuticals Consumption by Type (2015-2020) (K Dose)
Table 49. Europe Radiopharmaceuticals Consumption Market Share by Type (2015-2020)
Table 50. Europe Radiopharmaceuticals Consumption by Application (2015-2020) (K Dose)
Table 51. Europe Radiopharmaceuticals Consumption Market Share by Application (2015-2020)
Table 52. Middle East & Africa Radiopharmaceuticals Consumption by Countries (2015-2020) (K Dose)
Table 53. Middle East & Africa Radiopharmaceuticals Consumption Market Share by Countries (2015-2020)
Table 54. Middle East & Africa Radiopharmaceuticals Value by Countries (2015-2020) ($ Millions)
Table 55. Middle East & Africa Radiopharmaceuticals Value Market Share by Countries (2015-2020)
Table 56. Middle East & Africa Radiopharmaceuticals Consumption by Type (2015-2020) (K Dose)
Table 57. Middle East & Africa Radiopharmaceuticals Consumption Market Share by Type (2015-2020)
Table 58. Middle East & Africa Radiopharmaceuticals Consumption by Application (2015-2020) (K Dose)
Table 59. Middle East & Africa Radiopharmaceuticals Consumption Market Share by Application (2015-2020)
Table 60. Radiopharmaceuticals Distributors List
Table 61. Radiopharmaceuticals Customer List
Table 62. Global Radiopharmaceuticals Consumption Forecast by Countries (2021-2025) (K Dose)
Table 63. Global Radiopharmaceuticals Consumption Market Forecast by Regions
Table 64. Global Radiopharmaceuticals Value Forecast by Countries (2021-2025) ($ Millions)
Table 65. Global Radiopharmaceuticals Value Market Share Forecast by Regions
Table 66. Global Radiopharmaceuticals Consumption Forecast by Type (2021-2025) (K Dose)
Table 67. Global Radiopharmaceuticals Consumption Market Share Forecast by Type (2021-2025)
Table 68. Global Radiopharmaceuticals Value Forecast by Type (2021-2025) ($ Millions)
Table 69. Global Radiopharmaceuticals Value Market Share Forecast by Type (2021-2025)
Table 70. Global Radiopharmaceuticals Consumption Forecast by Application (2021-2025) (K Dose)
Table 71. Global Radiopharmaceuticals Consumption Market Share Forecast by Application (2021-2025)
Table 72. Global Radiopharmaceuticals Value Forecast by Application (2021-2025) ($ Millions)
Table 73. Global Radiopharmaceuticals Value Market Share Forecast by Application (2021-2025)
Table 74. Bracco Imaging Product Offered
Table 75. Bracco Imaging Radiopharmaceuticals Sales (K Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2020E)
Table 76. Bracco Imaging Main Business
Table 77. Bracco Imaging Latest Developments
Table 78. Bracco Imaging Basic Information, Company Total Revenue (in $ million), Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 79. Jubilant Pharma Product Offered
Table 80. Jubilant Pharma Radiopharmaceuticals Sales (K Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2020E)
Table 81. Jubilant Pharma Main Business
Table 82. Jubilant Pharma Latest Developments
Table 83. Jubilant Pharma Basic Information, Company Total Revenue (in $ million), Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 84. Bayer Product Offered
Table 85. Bayer Radiopharmaceuticals Sales (K Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2020E)
Table 86. Bayer Main Business
Table 87. Bayer Latest Developments
Table 88. Bayer Basic Information, Company Total Revenue (in $ million), Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 89. Nordion Product Offered
Table 90. Nordion Radiopharmaceuticals Sales (K Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2020E)
Table 91. Nordion Main Business
Table 92. Nordion Latest Developments
Table 93. Nordion Basic Information, Company Total Revenue (in $ million), Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 94. Triad Isotopes Product Offered
Table 95. Triad Isotopes Radiopharmaceuticals Sales (K Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2020E)
Table 96. Triad Isotopes Main Business
Table 97. Triad Isotopes Latest Developments
Table 98. Triad Isotopes Basic Information, Company Total Revenue (in $ million), Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 99. Mallinckrodt Product Offered
Table 100. Mallinckrodt Radiopharmaceuticals Sales (K Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2020E)
Table 101. Mallinckrodt Main Business
Table 102. Mallinckrodt Latest Developments
Table 103. Mallinckrodt Basic Information, Company Total Revenue (in $ million), Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 104. GE Healthcare Product Offered
Table 105. GE Healthcare Basic Information, Company Total Revenue (in $ million), Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 106. GE Healthcare Main Business
Table 107. GE Healthcare Latest Developments
Table 108. GE Healthcare Radiopharmaceuticals Sales (K Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2020E)
Table 109. Lantheus Product Offered
Table 110. Lantheus Radiopharmaceuticals Sales (K Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2020E)
Table 111. Lantheus Main Business
Table 112. Lantheus Latest Developments
Table 113. Lantheus Basic Information, Company Total Revenue (in $ million), Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 114. China Isotope & Radiation Product Offered
Table 115. China Isotope & Radiation Radiopharmaceuticals Sales (K Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2020E)
Table 116. China Isotope & Radiation Main Business
Table 117. China Isotope & Radiation Latest Developments
Table 118. China Isotope & Radiation Basic Information, Company Total Revenue (in $ million), Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 119. IBA Group Product Offered
Table 120. IBA Group Radiopharmaceuticals Sales (K Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2020E)
Table 121. IBA Group Main Business
Table 122. IBA Group Latest Developments
Table 123. IBA Group Basic Information, Company Total Revenue (in $ million), Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 124. Eli Lilly Product Offered
Table 125. Eli Lilly Radiopharmaceuticals Sales (K Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2020E)
Table 126. Eli Lilly Main Business
Table 127. Eli Lilly Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 128. Eli Lilly Latest Developments
Table 129. Dongcheng Product Offered
Table 130. Dongcheng Radiopharmaceuticals Sales (K Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2020E)
Table 131. Dongcheng Main Business
Table 132. Dongcheng Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 133. Dongcheng Latest Developments
Table 134. SIEMENS Product Offered
Table 135. SIEMENS Radiopharmaceuticals Sales (K Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2020E)
Table 136. SIEMENS Main Business
Table 137. SIEMENS Latest Developments
Table 138. SIEMENS Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 139. Navidea Product Offered
Table 140. Navidea Radiopharmaceuticals Sales (K Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2020E)
Table 141. Navidea Main Business
Table 142. Navidea Latest Developments
Table 143. Navidea Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 144. Advanced Accelerator Applications Product Offered
Table 145. Advanced Accelerator Applications Radiopharmaceuticals Sales (K Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2020E)
Table 146. Advanced Accelerator Applications Main Business
Table 147. Advanced Accelerator Applications Latest Developments
Table 148. Advanced Accelerator Applications Basic Information, Manufacturing Base, Sales Area and Its Competitors

List of Figures

Figure 1. Picture of Radiopharmaceuticals
Figure 2. Radiopharmaceuticals Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global Radiopharmaceuticals Consumption Growth Rate 2015-2025 (K Dose)
Figure 5. Global Radiopharmaceuticals Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of Diagnostic Radioisotopes
Figure 7. Product Picture of Therapeutic Radioisotopes
Figure 8. Global Radiopharmaceuticals Consumption Market Share by Type (2015-2020)
Figure 9. Global Radiopharmaceuticals Value Market Share by Type (2015-2020)
Figure 10. Radiopharmaceuticals Consumed in Oncology
Figure 11. Global Radiopharmaceuticals Market: Oncology (2015-2020) (K Dose)
Figure 12. Global Radiopharmaceuticals Market: Oncology (2015-2020) ($ Millions)
Figure 13. Radiopharmaceuticals Consumed in Cardiology
Figure 14. Global Radiopharmaceuticals Market: Cardiology (2015-2020) (K Dose)
Figure 15. Global Radiopharmaceuticals Market: Cardiology (2015-2020) ($ Millions)
Figure 16. Radiopharmaceuticals Consumed in Other
Figure 17. Global Radiopharmaceuticals Market: Other (2015-2020) (K Dose)
Figure 18. Global Radiopharmaceuticals Market: Other (2015-2020) ($ Millions)
Figure 19. Global Radiopharmaceuticals Consumption Market Share by Application (2015-2020)
Figure 20. Global Radiopharmaceuticals Value Market Share by Application (2015-2020)
Figure 21. Global Radiopharmaceuticals Sales Market Share by Company in 2017
Figure 22. Global Radiopharmaceuticals Sales Market Share by Company in 2019
Figure 23. Global Radiopharmaceuticals Revenue Market Share by Company in 2017
Figure 24. Global Radiopharmaceuticals Revenue Market Share by Company in 2019
Figure 25. Global Radiopharmaceuticals Sale Price by Company in 2019
Figure 26. Global Radiopharmaceuticals Consumption Market Share by Regions 2015-2020
Figure 27. Global Radiopharmaceuticals Value Market Share by Regions 2015-2020
Figure 28. Americas Radiopharmaceuticals Consumption 2015-2020 (K Dose)
Figure 29. Americas Radiopharmaceuticals Value 2015-2020 ($ Millions)
Figure 30. APAC Radiopharmaceuticals Consumption 2015-2020 (K Dose)
Figure 31. APAC Radiopharmaceuticals Value 2015-2020 ($ Millions)
Figure 32. Europe Radiopharmaceuticals Consumption 2015-2020 (K Dose)
Figure 33. Europe Radiopharmaceuticals Value 2015-2020 ($ Millions)
Figure 34. Middle East & Africa Radiopharmaceuticals Consumption 2015-2020 (K Dose)
Figure 35. Middle East & Africa Radiopharmaceuticals Value 2015-2020 ($ Millions)
Figure 36. Americas Radiopharmaceuticals Consumption Market Share by Countries in 2019
Figure 37. Americas Radiopharmaceuticals Value Market Share by Countries in 2019
Figure 38. Americas Radiopharmaceuticals Consumption Market Share by Type in 2019
Figure 39. Americas Radiopharmaceuticals Consumption Market Share by Application in 2019
Figure 40. United States Radiopharmaceuticals Consumption Growth 2015-2020 (K Dose)
Figure 41. United States Radiopharmaceuticals Value Growth 2015-2020 ($ Millions)
Figure 42. Canada Radiopharmaceuticals Consumption Growth 2015-2020 (K Dose)
Figure 43. Canada Radiopharmaceuticals Value Growth 2015-2020 ($ Millions)
Figure 44. Mexico Radiopharmaceuticals Consumption Growth 2015-2020 (K Dose)
Figure 45. Mexico Radiopharmaceuticals Value Growth 2015-2020 ($ Millions)
Figure 46. APAC Radiopharmaceuticals Consumption Market Share by Countries in 2019
Figure 47. APAC Radiopharmaceuticals Value Market Share by Regions in 2019
Figure 48. APAC Radiopharmaceuticals Consumption Market Share by Type in 2019
Figure 49. APAC Radiopharmaceuticals Consumption Market Share by Application in 2019
Figure 50. China Radiopharmaceuticals Consumption Growth 2015-2020 (K Dose)
Figure 51. China Radiopharmaceuticals Value Growth 2015-2020 ($ Millions)
Figure 52. Japan Radiopharmaceuticals Consumption Growth 2015-2020 (K Dose)
Figure 53. Japan Radiopharmaceuticals Value Growth 2015-2020 ($ Millions)
Figure 54. Korea Radiopharmaceuticals Consumption Growth 2015-2020 (K Dose)
Figure 55. Korea Radiopharmaceuticals Value Growth 2015-2020 ($ Millions)
Figure 56. Southeast Asia Radiopharmaceuticals Consumption Growth 2015-2020 (K Dose)
Figure 57. Southeast Asia Radiopharmaceuticals Value Growth 2015-2020 ($ Millions)
Figure 58. India Radiopharmaceuticals Consumption Growth 2015-2020 (K Dose)
Figure 59. India Radiopharmaceuticals Value Growth 2015-2020 ($ Millions)
Figure 60. Australia Radiopharmaceuticals Consumption Growth 2015-2020 (K Dose)
Figure 61. Australia Radiopharmaceuticals Value Growth 2015-2020 ($ Millions)
Figure 62. Europe Radiopharmaceuticals Consumption Market Share by Countries in 2019
Figure 63. Europe Radiopharmaceuticals Value Market Share by Countries in 2019
Figure 64. Europe Radiopharmaceuticals Consumption Market Share by Type in 2019
Figure 65. Europe Radiopharmaceuticals Consumption Market Share by Application in 2019
Figure 66. Germany Radiopharmaceuticals Consumption Growth 2015-2020 (K Dose)
Figure 67. Germany Radiopharmaceuticals Value Growth 2015-2020 ($ Millions)
Figure 68. France Radiopharmaceuticals Consumption Growth 2015-2020 (K Dose)
Figure 69. France Radiopharmaceuticals Value Growth 2015-2020 ($ Millions)
Figure 70. UK Radiopharmaceuticals Consumption Growth 2015-2020 (K Dose)
Figure 71. UK Radiopharmaceuticals Value Growth 2015-2020 ($ Millions)
Figure 72. Italy Radiopharmaceuticals Consumption Growth 2015-2020 (K Dose)
Figure 73. Italy Radiopharmaceuticals Value Growth 2015-2020 ($ Millions)
Figure 74. Russia Radiopharmaceuticals Consumption Growth 2015-2020 (K Dose)
Figure 75. Russia Radiopharmaceuticals Value Growth 2015-2020 ($ Millions)
Figure 76. Middle East & Africa Radiopharmaceuticals Consumption Market Share by Countries in 2019
Figure 77. Middle East & Africa Radiopharmaceuticals Value Market Share by Countries in 2019
Figure 78. Middle East & Africa Radiopharmaceuticals Consumption Market Share by Type in 2019
Figure 79. Middle East & Africa Radiopharmaceuticals Consumption Market Share by Application in 2019
Figure 80. Egypt Radiopharmaceuticals Consumption Growth 2015-2020 (K Dose)
Figure 81. Egypt Radiopharmaceuticals Value Growth 2015-2020 ($ Millions)
Figure 82. South Africa Radiopharmaceuticals Consumption Growth 2015-2020 (K Dose)
Figure 83. South Africa Radiopharmaceuticals Value Growth 2015-2020 ($ Millions)
Figure 84. Israel Radiopharmaceuticals Consumption Growth 2015-2020 (K Dose)
Figure 85. Israel Radiopharmaceuticals Value Growth 2015-2020 ($ Millions)
Figure 86. Turkey Radiopharmaceuticals Consumption Growth 2015-2020 (K Dose)
Figure 87. Turkey Radiopharmaceuticals Value Growth 2015-2020 ($ Millions)
Figure 88. GCC Countries Radiopharmaceuticals Consumption Growth 2015-2020 (K Dose)
Figure 89. GCC Countries Radiopharmaceuticals Value Growth 2015-2020 ($ Millions)
Figure 90. Global Radiopharmaceuticals Consumption Growth Rate Forecast (2021-2025) (K Dose)
Figure 91. Global Radiopharmaceuticals Value Growth Rate Forecast (2021-2025) ($ Millions)
Figure 92. Americas Radiopharmaceuticals Consumption 2021-2025 (K Dose)
Figure 93. Americas Radiopharmaceuticals Value 2021-2025 ($ Millions)
Figure 94. APAC Radiopharmaceuticals Consumption 2021-2025 (K Dose)
Figure 95. APAC Radiopharmaceuticals Value 2021-2025 ($ Millions)
Figure 96. Europe Radiopharmaceuticals Consumption 2021-2025 (K Dose)
Figure 97. Europe Radiopharmaceuticals Value 2021-2025 ($ Millions)
Figure 98. Middle East & Africa Radiopharmaceuticals Consumption 2021-2025 (K Dose)
Figure 99. Middle East & Africa Radiopharmaceuticals Value 2021-2025 ($ Millions)
Figure 100. United States Radiopharmaceuticals Consumption 2021-2025 (K Dose)
Figure 101. United States Radiopharmaceuticals Value 2021-2025 ($ Millions)
Figure 102. Canada Radiopharmaceuticals Consumption 2021-2025 (K Dose)
Figure 103. Canada Radiopharmaceuticals Value 2021-2025 ($ Millions)
Figure 104. Mexico Radiopharmaceuticals Consumption 2021-2025 (K Dose)
Figure 105. Mexico Radiopharmaceuticals Value 2021-2025 ($ Millions)
Figure 106. Brazil Radiopharmaceuticals Consumption 2021-2025 (K Dose)
Figure 107. Brazil Radiopharmaceuticals Value 2021-2025 ($ Millions)
Figure 108. China Radiopharmaceuticals Consumption 2021-2025 (K Dose)
Figure 109. China Radiopharmaceuticals Value 2021-2025 ($ Millions)
Figure 110. Japan Radiopharmaceuticals Consumption 2021-2025 (K Dose)
Figure 111. Japan Radiopharmaceuticals Value 2021-2025 ($ Millions)
Figure 112. Korea Radiopha
  • Global Radiopharmaceutical Market Insights and Forecast to 2027
    Published: 12-May-2021        Price: US 4900 Onwards        Pages: 154
    Radiopharmaceutical market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Radiopharmaceutical market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2016-2027. Segment by Type - Actinium-225 - Lutetium-177 - Radium-223 - Holmium-166 - Other ......
  • Global Radiopharmaceutical Market Research Report 2021
    Published: 12-Apr-2021        Price: US 2900 Onwards        Pages: 128
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - Actinium-225 - Lutetium-177 - Radium-223 - Holmium-166 - Other Segment by Appl......
  • 2020-2025 Global Radiopharmaceuticals Market Report - Production and Consumption Professional Analysis (Impact of COVID-19)
    Published: 08-Apr-2021        Price: US 3360 Onwards        Pages: 116
    A radiopharmaceutical or drug radioactive compound is a group of radioactive drugs. Radiopharmaceuticals are useful as diagnostic and therapeutic agents. The radiopharmaceutical itself emits radiation, which is different from contrast agents that absorb or alter external electromagnetic or ultrasonic waves. This report elaborates the market size, market characteristics, and market growth of the Radiopharmaceuticals industry, and breaks down according to the type, application, and consumpt......
  • Global Radiopharmaceuticals Sales Market Report 2021
    Published: 31-Mar-2021        Price: US 4000 Onwards        Pages: 146
    The global Radiopharmaceuticals market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Radiopharmaceuticals market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027. Segment by Type - Diagnostic Radioisotopes - Therapeu......
  • Global Radiopharmaceutical Market Growth 2021-2026
    Published: 25-Mar-2021        Price: US 3660 Onwards        Pages: 161
    According to this latest study, the 2021 growth of Radiopharmaceutical will have significant change from previous year. By the most conservative estimates of global Radiopharmaceutical market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 6270.7 million in 2020. Over the next five years the Radiopharmaceutical market will register a 8.9% CAGR in terms of revenue, the global market size will reach US$ 8826.1 million by 2026. This re......
  • Global Radiopharmaceuticals Market Growth 2021-2026
    Published: 19-Mar-2021        Price: US 3660 Onwards        Pages: 166
    According to this latest study, the 2021 growth of Radiopharmaceuticals will have significant change from previous year. By the most conservative estimates of global Radiopharmaceuticals market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 6123.9 million in 2020. Over the next five years the Radiopharmaceuticals market will register a 8.3% CAGR in terms of revenue, the global market size will reach US$ 8424.2 million by 2026. This......
  • Global Radiopharmaceutical Sales Market Report 2021
    Published: 11-Mar-2021        Price: US 4000 Onwards        Pages: 143
    The global Radiopharmaceutical market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Radiopharmaceutical market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027. Segment by Type - Actinium-225 - Lutetium-177 - ......
  • Radiopharmaceuticals Market - Global Outlook and Forecast 2021-2027
    Published: 05-Mar-2021        Price: US 3250 Onwards        Pages: 102
    This report contains market size and forecasts of Radiopharmaceuticals in global, including the following market information: Global Radiopharmaceuticals Market Revenue, 2016-2021, 2022-2027, ($ millions) Global Radiopharmaceuticals Market Sales, 2016-2021, 2022-2027, (K Dose) Global top five Radiopharmaceuticals companies in 2020 (%) The global Radiopharmaceuticals market was valued at 6441.3 million in 2020 and is projected to reach US$ 8652.2 million by 2027, at a ......
  • Global Radiation Dose Management Market Research Report with Opportunities and Strategies to Boost Growth- COVID-19 Impact and Recovery
    Published: 02-Mar-2021        Price: US 3500 Onwards        Pages: 113
    The radiation dose management channel includes information of radiation dose recording software, real-time staff dose monitoring, regulatory compliance and technology to reduce dose, including interative reconstruction software. Based on the Radiation Dose Management market development status, competitive landscape and development model in different regions of the world, this report is dedicated to providing niche markets, potential risks and comprehensive competitive strategy analysis in......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs